Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by InitiumMMXXIIIon Mar 29, 2024 9:48am
338 Views
Post# 35959982

Abandonment? Looks like it.

Abandonment? Looks like it.
It looks like the Bioasis executive and BoD have not paid or otherwise renewed the SSL Certificate fees for the Bioasis website (https://bioasis.us), leaving the website unavailable. 
 
This indicates to me that the executive and BoD have either given up all efforts to look after Bioasis in any manner, or that the neglect is intentional to allow other actions to take place without reporting them. Has Lind acquired the IP? It’s almost a year since the update on that, with the deadline for foreclosure then stated to be almost a year ago. Who owns the xB3 platform now?
 
I looked in my browser history and found that I had last visited the Bioasis website about a month ago, on February 27, 2024. As of that date the site was still making all of Bioasis’s historic claims about xB3 and the EGF stuff. I knew that Bioasis stock trading would soon be halted and I felt that as of February 27 the company was irresponsibly allowing the trading to take place despite the website and corporate presentation containing false information, more than I can be bothered to list here.
 
SSL certificates cost less than US$50.00, and are actually free with some web hosting services. The fact that the SSL Certificate has not been updated may be intentional to create the appearance of abandonment of Bioasis by its executive and BoD. A lot of questions come up as a result.
 
It should be noted that, as of Bioasis’s last press release in June 2023, the company was still stating the potential of xB3 and EGF in positive terms. The website did the same as late as February 27, 2024. I think regulators ought to begin investigating everything about Bioasis. I would welcome that and I would help in any way I can.
 
jd
 
<< Previous
Bullboard Posts
Next >>